Safety issues with drug therapies for autism spectrum disorders.
about
Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?Progress of mesenchymal stem cell therapy for neural and retinal diseasesReward processing in autism: a thematic series.Managing anxiety and depressive symptoms in adults with autism-spectrum disorders.Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher SurveyEvidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disordersPerspectives on the use of stem cells for autism treatmentPsychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts
P2860
Q21285056-29F74114-6BC5-4E15-BCBB-4A3AC110391DQ27015716-FAEAF024-AB0E-455E-AE2A-96EC6161F7D6Q30462673-97FFF227-ED55-48F8-9626-D16DFF23C03DQ35061750-ECD2F9C8-0B8B-4D67-9221-88F7BA4E3A20Q35985482-34D0424C-A7CE-452F-AFAE-6A3D8E651B4FQ36703079-3A52744B-92D8-4664-B976-DC4CA97EA4A5Q36873932-C8F79EF3-6BAA-4FFD-93CB-17E0128B91B5Q38162181-956E3C7B-F686-4228-BFB5-DBFDF2CB5433Q41247017-7DD54A18-85B8-4F80-85C2-B2F398C329CD
P2860
Safety issues with drug therapies for autism spectrum disorders.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Safety issues with drug therapies for autism spectrum disorders.
@ast
Safety issues with drug therapies for autism spectrum disorders.
@en
type
label
Safety issues with drug therapies for autism spectrum disorders.
@ast
Safety issues with drug therapies for autism spectrum disorders.
@en
prefLabel
Safety issues with drug therapies for autism spectrum disorders.
@ast
Safety issues with drug therapies for autism spectrum disorders.
@en
P1476
Safety issues with drug therapies for autism spectrum disorders
@en
P2093
James T McCracken
P478
66 Suppl 10
P577
2005-01-01T00:00:00Z